Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib
- 15 August 2003
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 92 (4), 411-418
- https://doi.org/10.1016/s0002-9149(03)00659-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Cardiovascular Thrombotic Events in Controlled, Clinical Trials of RofecoxibCirculation, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Potential utility of COX-2 inhibitors in chemoprevention and chemotherapyExpert Opinion on Investigational Drugs, 1999
- Use of Meta-Analysis to Evaluate Medical Questions of Interest: An Application to Studies of Secondary Prevention of Acute Myocardial InfarctionDrug Information Journal, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Aspirin as a Therapeutic Agent in Cardiovascular DiseaseCirculation, 1997
- Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol)Prostaglandins, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958